Contagious diseases like measles, COVID-19, influenza, norovirus, and tuberculosis pose significant global health challenges.

First, the phase 3 trial of Moderna’s norovirus vaccine had to endure a clinical hold. | First, the phase 3 trial of ...

Outbreaks of norovirus, an extremely contagious stomach bug, can spread quickly. “‘Tis the season for germs,” said Dr.

Dynavax is paying $30 million upfront for global rights to Vaxart’s investigational oral COVID-19 vaccine candidate, positioning the biotech to see phase 2b data before placing a bigger bet on the ...

A recent Indian Council of Medical Research (ICMR) study made some shocking revelations. It discovered that one in nine ...

A hospital is "extremely busy" with growing numbers of norovirus, flu and Covid cases. University Hospitals Sussex NHS Foundation Trust said high numbers of people are attending Worthing Hospital. Due ...

COVID-19 is in the “High” category in Essex Junction and Montpelier, and in the “Medium” category in South Burlington. There ...

Moderna reported third-quarter financial results on Thursday. The transcript from the company's earnings call has been provided below.

Reports third quarter revenue of $1.0 billion, GAAP net loss of $ (0.2) billion and GAAP EPS of $ (0.51) Improves 2025 ...

Dynavax Technologies Corporation , a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, and Vaxart, Inc. , a clinical-stage biotechnology company developing ...

Vaxart ( ($VXRT) ) has shared an announcement. On November 4, 2025, Vaxart entered into an exclusive license and collaboration agreement with ...

Children aged 2-3 years old, as well as school-age children (reception to year 11) and children with certain long-term health ...